These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15929468)

  • 1. [New approaches in pharmacology: numerical modelling and simulation].
    Boissel JP; Cucherat M; Nony P; Dronne MA; Kassaï B; Chabaud S
    Therapie; 2005; 60(1):1-15. PubMed ID: 15929468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Systems Pharmacology to Assess Drug's Therapeutic and Toxic Effects.
    Aguayo-Orozco A; Audouze K; Brunak S; Taboureau O
    Curr Pharm Des; 2016; 22(46):6895-6902. PubMed ID: 27604605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 18th FRAME Annual Lecture, October 2019: Human
    Rodriguez B
    Altern Lab Anim; 2019; 47(5-6):221-227. PubMed ID: 32090621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of ADMET Properties.
    Norinder U; Bergström CA
    ChemMedChem; 2006 Sep; 1(9):920-37. PubMed ID: 16952133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug research: from the idea to the product.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How modeling and simulation have enhanced decision making in new drug development.
    Miller R; Ewy W; Corrigan BW; Ouellet D; Hermann D; Kowalski KG; Lockwood P; Koup JR; Donevan S; El-Kattan A; Li CS; Werth JL; Feltner DE; Lalonde RL
    J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):185-97. PubMed ID: 16283534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.
    Gieschke R; Steimer JL
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):49-58. PubMed ID: 11032091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
    Paciorek CJ; Liu Y;
    Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems biology: an evolving approach in drug discovery and development.
    Ho RL; Lieu CA
    Drugs R D; 2008; 9(4):203-16. PubMed ID: 18588352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-based approaches to in silico pharmacology.
    Vidal D; Garcia-Serna R; Mestres J
    Methods Mol Biol; 2011; 672():489-502. PubMed ID: 20838981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics and systems biology--how relevant are the developments to veterinary pharmacology, toxicology and therapeutics?
    Witkamp RF
    J Vet Pharmacol Ther; 2005 Jun; 28(3):235-45. PubMed ID: 15953196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What does systems biology mean for drug development?
    Schrattenholz A; Soskić V
    Curr Med Chem; 2008; 15(15):1520-8. PubMed ID: 18537627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future directions of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling and simulation: population approach group in Europe 19th annual meeting.
    Kloft C; Poggesi I
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1599-604. PubMed ID: 20969486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome simulation approaches for synthesizing in silico datasets for human genomics.
    Ritchie MD; Bush WS
    Adv Genet; 2010; 72():1-24. PubMed ID: 21029846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PK/PD modelling and simulations: utility in drug development.
    Rajman I
    Drug Discov Today; 2008 Apr; 13(7-8):341-6. PubMed ID: 18405847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whither pharmacometrics?: present state and future choices.
    Vicini P; Smith BP
    Clin Pharmacol Ther; 2014 Jun; 95(6):567-71. PubMed ID: 24842634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial simulation in drug development.
    Girard P; Cucherat M; Guez D;
    Therapie; 2004; 59(3):287-95, 297-304. PubMed ID: 15559184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico modelling of physiologic systems.
    Colquitt RB; Colquhoun DA; Thiele RH
    Best Pract Res Clin Anaesthesiol; 2011 Dec; 25(4):499-510. PubMed ID: 22099916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to shock and trauma research: learning from multidisciplinary exchange.
    Neugebauer EA; Tjardes T;
    J Trauma; 2004 May; 56(5):1156-65. PubMed ID: 15179266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.